Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Sarcoma 1Other solid neoplasm 1Genitourinary 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Retinoblastoma 1Neuroblastoma 1Glioma 1

Interventions

Filgrastim 6Granulocyte Colony-Stimulating Factor 5Carboplatin 4Thiotepa 3Peripheral Blood Stem Cell Transplantation 3Etoposide 3Cyclophosphamide 3Topotecan 2racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1cixutumumab 1becatecarin 1alvocidib 1Vincristine 1Thrombopoietin 1Temozolomide 1Sirolimus 1Simvastatin 1Radiotherapy 1Nivolumab 1Methotrexate 1Melphalan 1Leucovorin 1LY2940680 1Itraconazole 1Immunologic Techniques 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × racotumomab × Other solid neoplasm × Clear all
NCT01598454 2015-07-29

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Laboratorio Elea Phoenix S.A.

Phase 1 Completed
15 enrolled
CNSGenitourinaryOther solid neoplasmSarcoma

Glioma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡